glp-1 alzheimer's 2025 🧠✨ New research is uncovering how GLP-1's originally designed for diabetes and weight management—may also play a role in protecting the brain against disease. From improving insulin sensitivity in the brain The Latest topics of Standards

Kynurenine serves as useful biomarker in acute, Long- and Post-COVID-19 diagnostics

When the benefit outweighs the side effect, and when it might not For most patients, the metabolic benefits of GLP-1 therapy, including improved cardiovascular risk factors, better insulin sensitivity, reduced visceral fat, and meaningful weight loss, far outweigh a temporary or modest change in libido

Have questions about your fitness journey or looking for expert advice on weightlifting techniques

Injection site reactions redness, swelling, tenderness occur in approximately 1520% of KLOW users and typically resolve within 2448 hours without intervention

(2) Marzook A, et al